Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CYTOKINETICS INC
BNP PARIBAS FINANCIAL MARKETS holds 854,374 shares of CYTK (CYTOKINETICS INC), worth $56.3M as of 2026-Q1. The position was increased (+47.3% shares). CYTK represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$56.3M
Current Shares
854,374
Total Value Change
+$53.3M
Total Shares Change
+798,453
Other major holders of CYTK: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 854,374 |
+47.3% |
| $56.3M |
| 0.0% |
| $60.72 |
40 |
| 2025-Q4 | Increased | 579,862 | +134.3% | $36.8M | 0.0% | $61.37 | 47 |
| 2025-Q3 | Decreased | 247,465 | -14.7% | $13.6M | 0.0% | $53.89 | 0 |
| 2025-Q2 | Increased | 290,245 | +22.2% | $9.6M | 0.0% | $33.16 | 33 |
| 2025-Q1 | Increased | 237,598 | +864.0% | $9.5M | 0.0% | $43.19 | 45 |
| 2024-Q4 | Decreased | 24,647 | -38.8% | $1.2M | 0.0% | $47.15 | 0 |
| 2024-Q3 | Decreased | 40,292 | -27.9% | $2.1M | 0.0% | $52.34 | 0 |
| 2024-Q2 | Decreased | 55,921 | -67.4% | $3M | 0.0% | $54.18 | 0 |